ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.
The pharmaceutical industry is under increasing pressure to develop new therapies at a faster pace, while lowering drug costs, enhancing quality, and maintaining safety and a robust supply chain. Validation 4.0 ensures that validation processes are not a bottleneck but a strategic enabler of innovation, quality, and compliance by embracing artificial intelligence (AI), Internet of Things...
As the pharmaceutical industry evolves, sustainability is becoming a key driver of operational efficiency and long-term success. From reducing carbon emissions to enhancing workforce safety, companies are aligning their practices with sustainability goals. The 2025 ISPE Annual Meeting & Expo is the ideal platform to exchange ideas and...
The pharmaceutical industry is no stranger to innovation. From pioneering drug development to advanced manufacturing processes, it thrives on new ideas. But when it comes to construction, particularly the delivery of critical infrastructure such as laboratories, cleanrooms, and research facilities, many companies in the sector still rely on traditional building methods.
The pharmaceutical sector is undergoing a profound transformation. As digital technologies continue to evolve, organizations are under increasing pressure to modernize legacy systems, enhance operational efficiency, and maintain compliance in a rapidly shifting regulatory landscape. The Digital Transformation track at the
Each issue of Pharmaceutical Engineering® covers a wide range of topics relevant to the pharmaceutical industry, including scientific, technological, and regulatory advancements throughout the entire...
On the closing morning of the 2025 ISPE Europe Annual Conference, Ian Jackson, an expert GMP inspector with the Medicines and Healthcare products Regulatory Agency (MHRA), presented MHRA’s Policy for the Future and Globalized Industry.
At the 2025 ISPE Europe Annual Conference held 12-14 May 2025 in London, the European Medicines Agency (EMA)’s Head of Quality and Safety of Medicines Department, Evdokia Korakianiti, highlighted the many...
